Using drugs to discriminate--adverse selection in the insurance marketplace.
暂无分享,去创建一个
[1] W. D. Dotson,et al. Public Awareness of Genetic Nondiscrimination Laws in Four States and Perceived Importance of Life Insurance Protections , 2015, Journal of Genetic Counseling.
[2] J. Gruber,et al. Choice Inconsistencies Among the Elderly: Evidence from Plan Choice in the Medicare Part D Program , 2009, The American economic review.
[3] Isaac S Kohane,et al. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine , 2014, Trials.
[4] B. Sommers,et al. Health reform and changes in health insurance coverage in 2014. , 2014, The New England journal of medicine.
[5] Emily Hoch,et al. Avoiding the Tragedy of the Commons in Health Care: Policy Options for Covering High-Cost Cures. , 2017, Rand health quarterly.
[6] R. Green,et al. Genetic testing for Alzheimer's and long-term care insurance. , 2010, Health affairs.
[7] J. Bard. When Public Health and Genetic Privacy Collide: Positive and Normative Theories Explaining How ACA's Expansion of Corporate Wellness Programs Conflicts with GINA's Privacy Rules , 2011, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.
[8] Robert C Green,et al. GINA, genetic discrimination, and genomic medicine. , 2015, The New England journal of medicine.